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Objective: Verbal autopsy (VA) is a systematic approach for determining causes of death (CoD) in populations
without routine medical certification. It has mainly been used in research contexts and involved relatively
lengthy interviews. Our objective here is to describe the process used to shorten, simplify, and standardise the
VA process to make it feasible for application on a larger scale such as in routine civil registration and vital
statistics (CRVS) systems.
Methods: A literature review of existing VA instruments was undertaken. The World Health Organization
(WHO) then facilitated an international consultation process to review experiences with existing VA
instruments, including those from WHO, the Demographic Evaluation of Populations and their Health in
Developing Countries (INDEPTH) Network, InterVA, and the Population Health Metrics Research
Consortium (PHMRC). In an expert meeting, consideration was given to formulating a workable VA CoD
list [with mapping to the International Classification of Diseases and Related Health Problems, Tenth Revision
(ICD-10) CoD] and to the viability and utility of existing VA interview questions, with a view to undertaking
systematic simplification.
Findings: A revised VA CoD list was compiled enabling mapping of all ICD-10 CoD onto 62 VA cause
categories, chosen on the grounds of public health significance as well as potential for ascertainment from VA.
A set of 221 indicators for inclusion in the revised VA instrument was developed on the basis of accumulated
experience, with appropriate skip patterns for various population sub-groups. The duration of a VA interview
was reduced by about 40% with this new approach.
Conclusions: The revised VA instrument resulting from this consultation process is presented here as a means
of making it available for widespread use and evaluation. It is envisaged that this will be used in conjunction
with automated models for assigning CoD from VA data, rather than involving physicians.
Keywords: verbal autopsy; cause of death; vital registration; civil registration; vital statistics; World Health Organization; InterVA
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nformation on causes of death (CoD) is essential for
planning, implementing, monitoring, and evaluating
public health at all levels. However, death registration
and CoD determination do not happen for many deaths
occurring in low- and middle-income countries (LMICs),
and the deaths of poorer people are much less likely to be
recorded, compounding inequalities. Statistical modelling
is used to fill the data gaps, for example, for maternal
deaths and malaria mortality. Facilitating complete and
accurate CoD determination and death registration in
LMICs is therefore a high priority. In the medium-term,
this will involve applying verbal autopsy (VA) not only
in surveillance sites and household surveys but also as
a routine part of civil registration and vital statistics
(CRVS) systems (1, 2).
VA ascertains probable CoD through interviews car-
ried out with caretakers of the deceased or witnesses
of deaths. The method uses questionnaires to elicit
pertinent information on signs, symptoms, and circum-
stances leading to death, generically described as indica-
tors, which are subsequently interpreted into CoD. VA
has been increasingly used in various contexts including
disease surveillance, sample registration systems, out-
break investigation, and measuring the impact of public
health interventions. Because vital registration coverage
has not significantly improved in most LMICs, VA data
collection has been conducted in a variety of settings
such as clinical trials and large-scale epidemiological
studies; demographic surveillance systems; national sam-
ple surveillance systems; and household surveys. The
expanding use of VA in generating mortality data has led
to a proliferation of different VA instruments (comprising
a set of questions/indicators that elicit pertinent infor-
mation on signs, symptoms and circumstances preceding
death and a corresponding list of CoD) that has impaired
data comparability across sites and over time. Limited
attention has been given to standardization of CoD
interpretation from VAs (3).
Users have different perspectives on the required level
of accuracy and categories of cause-specific mortality
data, with corresponding impacts on desirable charac-
teristics of VA instruments (4). However, the need for
regular nationally representative cause-specific mortal-
ity data in settings where a significant proportion of
deaths are not medically certified can only be met by
death registration including VA as part of national
CRVS systems. This requires simpler VA instruments
and operating procedures that can produce timely, readily
usable and reliable cause-specific mortality data.
To produce a simplified VA instrument, the World
Health Organization (WHO) carried out a systematic re-
view of VA instruments and procedures, followed by an ex-
pert consultation. Based on accumulated experience from
widely-used and validated VA procedures, consensus was
reached on a simplified VA instrument for routine use in
CRVS systems where deaths are not medically certified.
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The 2012 WHO VA instrument comprises a short CoD
list aligned to the International Classification of Diseases
and Related Health Problems, Tenth Revision (ICD-10)
that is ascertainable from a limited number of indica-
tors and amenable to automated processing. The design
allows adding a narrative and locally relevant questions
and diagnoses as needed. The rationale and processes
used to develop the 2012 WHO VA instrument are pre-
sented in this article.
VA instruments and procedures
The WHO first encouraged the use of lay reporting of
health information in 1956, and from then through the
1990s, developed lay reporting forms and published
key design features for studies based on VA methods.
With the expanding diversity and use of VA instruments,
demands for standardization led to the development of
the WHO VA standards in 2007 that included (5):
(1) VA questionnaires for three age groups (under 4
weeks; 4 weeks to 14 years; and 15 years and above);
(2) CoD certification and coding resources consistent
with ICD-10; and
(3) A CoD list for VA prepared according to the
ICD-10.
The 2007 WHO VA standards were partially based on
a VA instrument developed by the London School of
Hygiene and Tropical Medicine (LSHTM). The WHO
standards expected that up to three physicians trained in
VA coding would independently review individual ques-
tionnaire data  known as physician-certified VA (PCVA).
This procedure has been used by the International Net-
work for the Demographic Evaluation of Populations
and their Health in Developing Countries (INDEPTH)1
and by the Sample Vital Registration with Verbal
Autopsy (SAVVY).2
However, since PCVA is time-consuming and expensive,
computerized coding of VA (CCVA) methods for inter-
preting VA data have been investigated. Validated CCVA
methods can be algorithmic or probabilistic. Algorithmic
methods follow a set of predefined diagnostic criteria
that can be expert- or data-derived. The Tariff method is
an additive algorithm that uses Tariff scores reflecting
the importance and uniqueness of each symptom to each
CoD. The Artificial Neural Network (ANN) method
uses computer algorithms (machine learning), applying
non-linear statistics to pattern recognition. The Random
Forests method is a machine learning method for inter-
preting VA based on patterns of indicators from a
‘training dataset’ (6). Whereas algorithmic methods result
in binary outcomes (yes or no) for a single CoD, pro-
babilistic methods determine the probability of a range
of multiple causes. The InterVA method applies Bayesian
probabilistic methods to a matrix of indicators and CoD,
using conditional probabilities derived from available
data and expert opinion. This method has been available
in the public domain since 2006 (7, 8). King and Lu’s
algorithmic method is able to estimate cause-specific
mortality fractions (CSMFs) without individual CoD
assignment. The Simplified Symptom Pattern (SSP)
method is a data-driven Bayesian approach that combines
the King and Lu and InterVA methods.
Review of utilization of VA instruments and
procedures
Despite attempts to standardize and harmonize VA
instruments, there are multiple instruments in use (911).
We conducted a systematic literature review to deter-
mine how VA instruments have been used and the uptake
of the WHO VA standards published in 2007.
The review included studies reported in peer-reviewed
journals from 1986 up to early 2012. Figure 1 illustrates
the review process. The WHO instruments and the
three related ones briefly described above (INDEPTH,
SAVVY and LSHTM) were included in the review.
Instruments described as adapted from these were also
included. Studies that did not provide details of the
instrument used were excluded. A brief description of the
125 eligible studies is available as a Supplementary File.
Some studies applied different VA interpretation meth-
ods on the same dataset and were counted as a single
study for the review of the use of the VA instruments.
The selected VA instruments or their adaptations were
reported to be used by 112 studies in 41 countries. Table 1
summarizes the identified studies, data collection period,
and number of deaths certified, by each VA instrument.
VA was mostly used as a research tool in longitudinal
health and demographic surveillance and in interven-
tion or epidemiological studies. The first study identified
used an adapted version of an early WHO instrument to
certify perinatal deaths in Nepal in 1989 (12). From the
112 reviewed studies, 104 reported the number of deaths
certified, totalling 159,316. Studies using the INDEPTH
instrument certified the largest number of deaths, ranging
1INDEPTH (www.indepth-network.org) is a network of member
centres that conduct longitudinal health and demographic
evaluation of populations in LMICs. INDEPTH has built a
network of 44 health and demographic surveillance systems
(HDSS) across 20 countries in Africa, Asia, and Oceania. The
network strengthens capacity of HDSS centres, and mounts
multicentre research to guide health priorities and policies in
LMICs, based on up-to-date empirical scientific evidence. The
network uses VA as a method for determining CoD.
2SAVVY, proposed by MEASURE Evaluation and the International
Programs Center, U.S. Census Bureau, is a system to generate
reliable information on mortality levels and CoD at the national
level. The SAVVY resource library is a series of best practice
manuals and methods for improving the quality of vital statistics
where high coverage of civil registration and good CoD data are not
available. A SAVVY system collects mortality data from a number of
sites throughout a country using multistage probability sampling.
SAVVY Methods include determination of CoD with VA.
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from 100 to 38,306 deaths with a mean of 4269.4,
totalling 72,579 deaths (Table 1).
VA has also been applied in national health surveys.
In most surveys (e.g. Nepal Demographic and Health
Survey (DHS) 2006, Ghana DHS 2008, Bangladesh DHS
2011), this involves the identification of deaths among
children under 5 years in either the household schedule
or the individual interview of women of reproductive age,
followed by administration of a VA module. In Uganda,
deaths among children under 5 identified in the DHS
in 2007 were followed up in a subsequent survey in 2008.
In the Afghanistan Mortality Survey 2010, a VA was
3) LILACS
Search Terms
Verbal autopsy; post mortem interview; cause of death; mortality surveillance
1) 465 2) 203 3) 9
Titles and abstracts of all 677 publications were read by one of the authors, and all articles
on studies reporting to have used the WHO, INDEPTH, SAVVY, or LSHTM VA instruments or 
adaptations of the instruments were considered eligible for review. A total of 340 articles 
were excluded from the review based on the following criteria: (i) no description of VA 
instrumentused; (ii) did not use the WHO, INDEPTH, SAVVY, or LSHTM VA instruments or 
adapted versions of these instruments; (iii) not published in English, French, Spanish
or Portuguese.
The retained 125 studies were reviewed by one of the authors. Additional publications known
to any of the authors but not identified through the literature search, and references quoted 
in original publications, were also reviewed. 
Literature Databases searched and number of citations found
2) Popline1) PubMed
Fig. 1. Illustration of literature search and review process.
Table 1. Summary characteristics of reviewed studies (n112) by type of VA instrumenta
% of studies with sites
Number of
identified studies
Data collection
period
Mean and range of number
of deaths certified Africa Asia
Central and
South America
WHO VA instrument 31 (27.7%) 19922010 620.1 (234 239) 61.3 32.3 16.1
Adapted WHO VA instrument 42 (37.5%) 19892010 1 347.5 (212 542) 35.7 59.5 7.1
INDEPTH VA instrument 17 (15.2%) 19962009 4 269.4 (10038 306) 64.7 35.3 0
Adapted INDEPTH VA instrument 9 (8%) 19992010 590.7 (1641 816) 100 0 0
SAVVY instrument 1 (0.9%) 20072010 145 100 0 0
Adapted SAVVY instrument 3 (2.7%) 20062008 258 (252264) 33.3 0 66.7
LSHTM VA instrument 5 (4.5%) 19922002 407.3 (40796) 80 20 0
Adapted LSHTM VA instrument 4 (3.6%) 20032007 2 304.3 (1 0845 160) 25 75 0
aPercentages of studies conducted amount to more than 100% because some multicentre studies had sites in more than one continent.
Jordana Leitao et al.
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administered for deaths of all ages. In Mozambique, a
post census VA was conducted in 2008. All surveys ask
for medical certification of the CoD, but the majority rely
on VA using a variety of questionnaires.
Table 1 and Fig. 2 show that the majority of reviewed
studies had sites in Africa (54.5%) and Asia (40.2%), while
some were conducted in Central and South America
(8.9%). The majority of studies using the WHO (61.3%),
Fig. 2. Global distribution of verbal autopsy studies.
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INDEPTH (64.7%) or adapted versions of the INDEPTH
instruments (100%) were in Africa; studies using the
WHO (32.3%) or INDEPTH (35.3%) instruments also
had sites in Asia.
Use over time for each VA instrument is shown in
Fig. 3. Publications using the WHO and INDEPTH
VA instruments (and adaptations) increased around
1999, peaking between 2003 and 2005. There have been
a limited number of published studies using other
instruments. Since the publication of the WHO VA
standards in 2007, 17 studies have been conducted which
used the WHO VA instrument and adaptations (12/17);
the INDEPTH instrument and adaptations (2/17); and
the SAVVY instrument and adaptations (3/17). While
these figures show that the majority of studies since 2007
have used the WHO VA instrument and adaptations,
it is difficult to assess the level of uptake of the WHO VA
standards, as trends in more recent data collection years
may be difficult to interpret due to delays in publication
of results, particularly given delays in PCVA interpreta-
tion in some sites.
Age groups were reported by 110 studies. For compar-
isons, age groups were categorized non-exclusively as:
stillbirths; under 4 weeks; 4 weeks to 5 years; under 15
years; 15 years and above; maternal deaths; and all age
groups (Table 2). VA instruments have mostly been used
for 15 years and above (26.4%) and for all age groups
(22.7%). Deaths in children under 5 years old (18.2%) and
neonates (18.2%) have also been widely studied.
The most common interpretation method (more than
one was used in some studies) was the PCVA (82.9%),
followed by probabilistic methods (11.7%), and algo-
rithms (10.8%) (2). Of probabilistic methods, InterVA
was most used (61.5%). Only one study used ANN,
Random Forest, SSP, Tariff, or King and Lu methods
to ascertain CoD.
Validity studies for VA procedures are fraught with
difficulties since there is no widely available gold standard,
particularly for the majority of LMICs deaths not oc-
curring in health facilities (13). The validity of VA is
typically assessed by comparing hospital medical records
as gold standard diagnoses for CoD, as well as by making
between-method comparisons (e.g. between PCVA and
CCVA). The validity of the overall VA process is influenced
by the design and content of the questionnaires, field pro-
cedures, data interpretation methods, actual CoD pat-
terns, and characteristics of the deceased (14).
Of the 125 studies reviewed, 26 assessed performance
of VA procedures in certifying CoD (studies using the
same VA dataset but different CoD interpretation meth-
ods and/or assessing different validation parameters were
included in the review and counted as individual studies)
(Tables 3 and 4). Apart from adapted versions of the
LSHTM VA instrument, all other types of VA instruments
have been validated at least once by these studies. The
majority of studies validating VA procedures have used
the WHO VA instrument (6/26) and their adapted versions
(10/26). A similar review by Chandramohan et al. in 1994
identified almost no information on the validity of VA for
adult deaths (7). Our review identified that this trend has
shifted with most of the 26 studies having assessed the
performance for all CoD (21/26), in adults (10/26) and
in all age groups (10/26). These studies used a variety of
measures, including: sensitivity (14/26); specificity (14/26);
positive predictive value (PPV) (8/26); negative predictive
value (NPV) (4/26); cause-specific fractions (CSF) (1/26);
Table 2. Age groups studied by type of VA instrument (n110)a
Stillbirths
Under
4 weeks
Under
5 years
Under
15 years
Aged 15 years
and above
Maternal
deaths
All age
groups
WHO VA instrument 13.3% (4/30) 20.0% (6/30) 30.0% (9/30) 3.3% (1/30) 13.3% (7/30) 10.0% (3/30) 10.0% (3/30)
Adapted WHO VA
instrument
7.3% (3/41) 24.4% (10/41) 17.1% (7/41) 0% (0/41) 17.1% (7/41) 17.1% (7/41) 26.8% (11/41)
INDEPTH VA
instrument
5.9% (1/17) 11.8% (2/17) 11.8% (2/17) 11.8% (2/17) 17.6% (3/17) 0% (0/17) 47.1% (8/17)
Adapted INDEPTH
VA instrument
0% (0/9) 0% (0/9) 22.2% (2/9) 33.3% (3/9) 33.3% (3/9) 0% (0/9) 11.1% (1/9)
SAVVY instrument 0% (0/1) 0% (0/1) 0% (0/1) 0% (0/1) 100.0% (1/1) 0% (0/0) 0% (0/0)
Adapted SAVVY
instrument
33.3% (1/3) 66.7% (2/3) 0% (0/3) 0% (0/3) 33.3% (1/3) 0% (0/3) 0% (0/3)
LSHTM VA instrument 0% (0/5) 0% (0/5) 0% (0/5) 0% (0/5) 100.0% (5/5) 0% (0/5) 0% (0/5)
Adapted LSHTM
VA instrument
0% (0/4) 0% (0/4) 0% (0/4) 0% (0/4) 50.0% (2/4) 0% (0/4) 50.0% (2/4)
Total 8.2% (9/110) 18.2% (20/110) 18.2% (20/110) 5.5% (6/110) 26.4% (29/110) 9.1% (10/110) 22.7% (25/110)
aPercentages do not add up to 100% as some studies determined CoD in more than one age group.
Jordana Leitao et al.
6
(page number not for citation purpose)
Citation: Glob Health Action 2013, 6: 21518 - http://dx.doi.org/10.3402/gha.v6i0.21518
Table 3. Main characteristics of reviewed VA validation studies (n26)
Measures of validity
Number of validation
studies Sensitivity Specificity PPV NPV CSF
Concordance
between VA CSMF
and CSMF from
validation data
ROC
curve
Kappa
statistics
Cause-specific
and average
chance-corrected
concordance
CSMF
accuracy
Cause-specific concordance
correlation coefficients of
estimated CSMFs compared
to true CSMFs
Validated
against
hospital
CoD data
WHO VA instrument (n6) 6/6 6/6 2/6 2/6 1/6 1/6 1/6 0/6 0/6 0/6 0/6 6/6
Adapted WHO VA
instrument (n10)
3/10 2/10 2/10 1/10 0/10 2/10 0/10 2/10 5/10 6/10 6/10 9/10
INDEPTH VA instrument
(n3)
0/3 0/3 0/3 0/3 0/3 2/3 0/3 2/3 0/3 0/3 0/3 0/3
Adapted INDEPTH VA
instrument (n1)
1/1 1/1 1/1 0/1 0/1 1/1 1/1 1/1 0/1 0/1 0/1 0/1
SAVVY instrument (n1) 1/1 1/1 1/1 1/1 0/1 1/1 1/1 1/1 0/1 0/1 0/1 1/1
Adapted SAVVY instrument
(n1)
0/1 1/1 1/1 0/1 0/1 0/1 0/1 0/1 0/1 0/1 0/1 0/1
LSHTM VA instrument
(n4)
3/4 3/4 1/4 0/4 0/4 3/4 0/4 1/4 0/4 0/4 0/4 4/4
Total (n26) 14/26 14/26 8/26 4/26 1/26 10/26 3/26 7/26 5/26 6/26 6/26 20/26
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Table 4. List of reviewed VA validation studies (n26)
Instrument and source
VA interpretation
method
Number of
deaths certified
CoD
studied
Age groups
studied Validity and reliability parameters
WHO VA instrument (15) Physician review 225 All causes Stillbirths Sensitivity, Specificity, PPV, NPV, ROC curves
WHO VA instrument (16) Algorithms 1115 Diarrhoea and
pneumonia
Children under
5 years
Sensitivity, Specificity, CSMF
WHO VA instrument (17) Physician review 719 All causes Children under
5 years
Sensitivity, Specificity, PPV, Difference between CSMF estimated by VA
and true CSMF in validation data
WHO VA instrument (18) Physician review 763 Stroke Adults Sensitivity, Specificity
WHO VA instrument (19) Physician review 1251 All causes Stillbirths and neonates Sensitivity, Specificity
WHO VA instrument (20) Physician review 36 Selected childhood
illnesses
Children under 12
years old
Sensitivity, Specificity, PPV, NPV
Adapted WHO VA
instrument (21)
Physician review 255 All causes All age groups Sensitivity, Specificity
Adapted WHO VA
instrument (22)
Physician review 219 All causes Adults Sensitivity, Specificity, PPV, NPV, Kappa statistics
Adapted WHO VA
instrument (23)
Physician review
and InterVA
734 All causes Stillbirths and
neonates
Concordance of CSMFs estimated by InterVA and physician review,
Level of agreement between InterVA and physician assigned CoD using
Kappa statistics
Adapted WHO VA
instrument (24)
Physician review 9817 All causes All age groups Sensitivity, PPV, Concordance of CSMFs estimated by physician review
and medical record diagnoses
Adapted WHO VA
instrument (8)
InterVA, physician
review and SP method
12542 All causes All age groups Average of cause-specific chance-corrected concordance, CSMF
accuracy, relationship between estimated CSMFs and true CSMFs
Adapted WHO VA
instrument (25)
King Lu method and
physician review
12542 All causes All age groups CSMFs accuracy, relationship between estimated CSMFs and true
CSMFs
Adapted WHO VA
instrument (26)
Physician review 12542 All causes All age groups Average of cause-specific chance-corrected concordance, CSMFs
accuracy, Relationship between estimated CSMFs and true CSMFs
Adapted WHO VA
instrument (27)
Tariff method and
physician review
12542 All causes All age groups Average of cause-specific chance-corrected concordance, CSMFs
accuracy, Relationship between estimated CSMFs and true CSMFs
Adapted WHO VA
instrument (28)
SSP method and
physician review
12542 All causes All age groups Average of cause-specific chance-corrected concordance, CSMFs
accuracy, Relationship between estimated CSMFs and true
CSMFs
Adapted WHO VA
instrument (6)
Random Forests
method and physician
review
12542 All causes All age groups Average of cause-specific chance-corrected concordance, CSMFs
accuracy, Relationship between estimated CSMFs and true
CSMFs
INDEPTH VA
instrument (29)
Physician review and
InterVA
1823 All causes Children under
5 years and adults
Level of agreement between InterVA and physician assigned CoD using
Kappa statistics, Concordance of CSMFs estimated by InterVA and
physician review
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Table 4 (Continued)
Instrument and source
VA interpretation
method
Number of
deaths certified
CoD
studied
Age groups
studied Validity and reliability parameters
INDEPTH VA instrument
(30)
Physician review and
InterVA
10 267 All causes All age groups Level of agreement between InterVA and physician assigned CoD using
Kappa statistics
INDEPTH VA instrument
(31)
Physician review and
InterVA
289 All causes All age groups Concordance of CSMFs between InterVA and physician review
Adapted INDEPTH VA
instrument (32)
InterVA 193 HIV/AIDS Adults Sensitivity, Specificity, PPV, Concordance of CSMFs between InterVA
and the reference standard, Level of agreement between InterVA and
reference standard CoD using Kappa statistics, ROC curves
SAVVY instrument (33) Physician review and
InterVA
145 All causes Adults Sensitivity, Specificity, PPV, NPV, ROC curves, Level of agreement
between InterVA, physician review and hospital CoD using Kappa
statistics, Concordance of CSMFs between InterVA, physician review
and hospital CoD
Adapted SAVVY
instrument (34)
Physician review 264 HIV/AIDS Adults Specificity, PPV
LSHTM VA instrument
(35)
Physician review and
algorithms
615 All causes Adults Sensitivity, Specificity, Concordance of CSMF obtained using the
data-derived algorithms with the CSMF obtained using physician review
LSHTM VA instrument
(36)
Physician review and
expert algorithms
796 All causes Adults Sensitivity, Specificity, PPV, Concordance of CSMFs between physician
review, algorithms and hospital CoD
LSHTM VA instrument
(37)
Physician review,
expert algorithms
and data-derived
algorithms
796 All causes Adults Sensitivity, Specificity, Concordance of CSMFs between physician
review, algorithms and hospital CoD
LSHTM VA instrument
(38)
Data-derived
algorithms
40 All causes Adults Kappa statistics
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concordance between CSMF estimated by VA and CSMF
from the validation data (10/26); areas under the receiver
operator characteristic (ROC) curve (3/26); kappa statis-
tics (7/26); cause-specific and average chance-corrected
concordance (5/26); CSMF accuracy (6/26); and cause-
specific concordance correlation coefficients of estimated
CSMFs compared to true CSMFs (6/26). The ability of
these studies to adequately validate VA has often been
limited by small sample sizes, affecting reliability of meas-
ures such as sensitivity and specificity, and the absence
of certain causes from hospital data. Most studies (20/26)
relied on hospital CoD data as the standard measure
of validity. Exceptions included comparison studies using
the InterVA method (7/26), where in five studies the
reliability of VA procedure was assessed by the concor-
dance of CSMFs estimated by InterVA and PCVA. The
review found two studies validating the performance of
InterVA against hospital CoD data (8, 33).
Our reviewof VA studies published up to 2012 highlights
variability in the selection, development, and use of VA
instruments, as well as in methods of assessment. The
review established that there are many adaptations of
standard VA instruments. Although instruments may
need to be adapted to local contexts, the extent of
modifications was not reported by studies and their impact
on VA performance and accuracy are not known. The
review was hindered by an absence of information on the
VA instrument used by a substantial number of studies.
The lack of systematic detailed information on methods
used undermines the value of experience sharing on use
of VA instruments and limits a more accurate under-
standing of the use of the different instruments and uptake
of VA guidelines. Some reports on using VA may have been
missed if written in other languages or as yet unpublished.
Simplification of VA standards: the 2012 WHO
VA instrument
In December 2011, following the above review process,
consensus over a simplified VA instrument was reached
among 37 experts from 15 countries in a meeting organ-
ized by WHO in collaboration with the University of
Queensland, the Health Metrics Network and INDEPTH.
The meeting was followed by a 2-day workshop during
which the outcomes of the discussions were consolidated.
Participants included key stakeholders, researchers, and
those who work routinely with VA instruments. The 2012
WHO VA instrument comprises a total of 221 CoD-related
indicators to certify 62 CoD. The instrument is designed
primarily for electronic data capture, and WHO data
collection software will facilitate this on generic mobile
devices. CoD interpretation software also allows assess-
ment without physicians, reducing cost and time lag in
VA interpretation, and enhancing comparability across
different settings and over time. For those wanting to
use paper capture and PCVA, simplified sample ques-
tionnaires have been developed for three age groups:
under 4 weeks; 4 weeks to 14 years; and 15 years and
over, which are available with all other aspects of the
2012 WHO VA instrument at www.who.int/healthinfo/
statistics/verbalautopsystandards
As determined by extensive skip patterns, the maximum
number of questions to be asked for any death ranges
from 104 for a neonatal death to 130 for a maternal death
(Table 5). Although users may need to add locally relevant
questions, the instrument as defined here should be
regarded as the core.
Simplified list of CoD
To develop a VA instrument appropriate for strengthen-
ing countries’ CRVS systems, we simplified the WHO
VA standards; this commenced with generating a shorter
list of CoD. Three main criteria characterized essential
CoD:
(1) Importance: most frequent CoD of global public
health relevance (e.g. acute respiratory infections);
(2) Diagnostic Feasibility: CoD associated with recog-
nizable symptoms ascertainable by VA (e.g. HIV/
AIDS); and
(3) Potential for intervention: CoD can be addressed by
public health interventions (e.g. diarrhoeal diseases).
Comparison of the results of most widely used and
validated VA instruments and interpretation approaches
Table 5. Pattern of indicators by age group
Number of indicators
Age group CoD-related
Skip level First Second Third Fourth Total Personal Respondent Context Total
15 years 56 37 27 10 130 26 3 10 169
4 weeks14 years 34 35 22 10 101 26 3 10 140
Under 28 days 44 35 15 10 104 26 3 10 143
Total 93 87 31 10 221
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Table 6. Correspondence of CoD between the 2007 WHO VA standards, InterVA and PHMRC VA instruments, the 2004 GBD,
and their reported percentage in 125 reviewed VA studies
2007 WHO VA standards 2004 GBD InterVA PHMRC VA instrument % Reported in various studies
Infectious and parasitic diseases
Sepsis + + 10.4
Acute respiratory infection, including pneumonia + + + 37.6
HIV/AIDS related death + + + 36.8
Intestinal infectious diseases + + + 40.8
Malaria + + + 33.6
Measles + + + 10.4
Meningitis + + + 30.4
Tetanus + 4.8
Pulmonary tuberculosis + + + 35.2
Typhoid and Paratyphoid 0.8
Pertussis + 2.4
Leishmaniasis 0
Viral hepatitis 6.4
Arthropod-borne viral fevers and viral haemorrhagic fevers + 4.0
Other infectious disease, unspecified + + 21.6
Neoplasms
Oral neoplasms + 4.0
Digestive neoplasms + + 12.0
Malignant neoplasm of rectum and anus + + 4.8
Respiratory neoplasms + + 8.0
Breast neoplasms + + 4.8
Reproductive neoplasms + + 10.4
Melanoma of skin 0
Neoplasm of lymphoid, haematopoietic and related tissue 0.8
Other and unspecified neoplasms + + 20.0
Nutritional and endocrine disorders
Severe anaemia 9.6
Severe malnutrition + + 16.0
Diabetes mellitus + + + 14.4
Other and unspecified nutritional and endocrine disorders 1.6
Diseases of circulatory system
Acute cardiac disease + + + 16.0
Sickle cell + 0.8
Cerebrovascular disease + + + 22.4
Other and unspecified cardiac disease + 44.0
Respiratory disorders
Chronic obstructive pulmonary disease (COPD) + 6.4
Asthma + 4.8
Other and unspecified respiratory disease + 20.8
Gastrointestinal diseases
Acute abdominal condition 6.4
Chronic liver disorder + + + 16.0
Other and unspecified digestive disease + + 13.6
Renal disorders
Renal failure + + + 14.4
Other and unspecified disorders of kidney and ureter 2.4
Mental and nervous system disorders
Mental disorder 2.4
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including PCVA, InterVA, and Population Health Metrics
Research Consortium (PHMRC) methods, enabled the
identification of a core group of CoD that can be certified
by VA. This core group of CoD was mapped against the
31 causes reported in the 2004 Global Burden of Disease
(GBD) study to ascertain the public health importance of
individual causes. Finally, consensus on the simplified list
of CoD was reached in the meeting with VA experts, based
on their experience and available evidence.
In the 2007 WHO VA standards, there were 106 pos-
sible CoD to be assigned by physicians, while InterVA-3
and InterVA-M assigned 48 causes and the PHMRC
VA instrument reached 51 (5, 31, 39). To facilitate com-
parison, some CoD from the WHO VA standards were
re-categorized, creating a set of mutually exclusive, collec-
tively exhaustive CoD categories. Table 6 displays the
results from the review and correlation of CoD between
the VA instruments and the GBD.
In the review of 125 studies covering 199,158 deaths
described above, we collated evidence on CoD certified
by VA and reported in studies to illustrate the range
of CoD that were observed and certifiable by VA. The top
10 CoD reported were: ‘other and unspecified cardiac dis-
ease’ (44%); ‘intestinal infectious diseases’ (40.8%); ‘acute
respiratory infections, including pneumonia’ (37.6%); ‘HIV/
AIDS-related death’ (36.8%); ‘pulmonary tuberculosis’
Table 6 (Continued)
2007 WHO VA standards 2004 GBD InterVA PHMRC VA instrument % Reported in various studies
Disease of nervous system + 3.2
Epilepsy/Acute seizures + 4.8
Pregnancy-, childbirth and puerperium-related disorders
Ectopic pregnancy + 1.6
Abortion-related death + 4.0
Pregnancy-induced hypertension + 9.6
Obstetric haemorrhage + 12.8
Obstructed labour + 5.6
Pregnancy-related sepsis + 8.8
Anaemia of pregnancy + 1.6
Ruptured uterus + 3.2
Other and unspecified maternal cause + + 20.8
Perinatal causes of death
Prematurity + + + 35.2
Perinatal asphyxia + + + 29.6
Neonatal pneumonia + + 8.8
Neonatal sepsis + + 20.8
Neonatal tetanus + 10.4
Congenital malformation + + + 27.2
Other diseases related to the perinatal period, unspecified 12.0
Stillbirth + 8.0
External causes
Road traffic accident + + + 9.6
Other transport accident + + 7.2
Accidental fall + + 6.4
Accidental drowning and submersion + + 9.6
Accidental exposure to smoke, fire and flames + + + 7.2
Contact with venomous animals and plants + + 3.2
Accidental poisoning and exposure to noxious substance + + 5.6
Intentional self-harm + + + 15.2
Assault, homicide, war + + + 14.3
Exposure to force of nature 0
Lack of food and/or water 0
Legal intervention 0
Accident, unspecified + 14.4
Other and unspecified external cause + + 25.6
Jordana Leitao et al.
12
(page number not for citation purpose)
Citation: Glob Health Action 2013, 6: 21518 - http://dx.doi.org/10.3402/gha.v6i0.21518
(35.2%); ‘prematurity’ (35.2%); ‘malaria’ (33.6%); ‘peri-
natal asphyxia’ (29.6%); ‘congenital malformations’
(27.2%); and ‘Other and unspecified external cause of
death’ (25.6%). In contrast, the 10 CoD certified and
reported least frequently were: ‘typhoid and paratyphoid’
(0.8%); ‘neoplasm of lymphoid, haematopoietic and
related tissue’ (0.8%); ‘sickle cell’ (0.8%); ‘ectopic preg-
nancy’ (1.6%); ‘anaemia of pregnancy’ (1.6%); ‘other and
unspecified nutritional and endocrine disorders’ (1.6%);
‘other and unspecified disorders of kidney and ureter’
(2.4%); ‘mental disorder’ (2.4%); ‘pertussis’ (2.4%); and
‘disease of nervous system’ (3.2%). The CoD ‘Leishma-
niasis’, ‘melanoma of skin’, ‘exposure to force of nature’,
‘lack of food and/or water’, and ‘legal intervention’
have not been certified by VA in any of the reviewed
studies.
Elimination of CoD was based on low frequency
reported by VA studies, not being included in the other
VA instruments, and on experts’ judgment about their
importance, feasibility and intervention potential. As a
result, 27 CoD from the 2007 WHO VA standards were
subsumed into residual categories, including ‘typhoid and
paratyphoid’, ‘leishmaniasis’, ‘melanoma of skin’, ‘lack
of food and/or water’ and ‘legal intervention’ (Table 7).
The inclusion of the majority of CoD in the simplified
CoD list was based on the consistency between CoD
from WHO VA standards against InterVA and PHMRC
VA, GBD estimates and coverage in VA studies. All
causes included in the GBD and the top 10 most certified
CoD reported were retained. During expert meetings, the
CoD ‘other and unspecified non-communicable disease’,
‘sepsis’, ‘anaemia of pregnancy’ and ‘ruptured uterus’
were added to the list. Although not in the GBD or most
commonly certified CoD, they were considered feasible
for VA certification, provide key information to CRVS,
contribute significant mortality burdens and are respon-
sive to interventions. Further modifications included
grouping related CoD not having readily distinguishable
symptoms into broader categories. For example, ‘malig-
nant neoplasm of cervix’ and ‘malignant neoplasm of
uterus’ were combined into ‘female reproductive neo-
plasms’. Overall, the simplification process led to a 41.5%
reduction in CoD compared with the WHO VA standards
CoD list, resulting in 60 CoD. A further two categories
were added for fresh and macerated stillbirths, despite
not strictly considered as CoD, because of their impor-
tance in some settings. Table 8 presents the simplified VA
CoD list, structuring the causes into groupings consistent
with ICD-10 and showing in the last column how all
ICD-10 codes map onto the 62 CoD.
VA questionnaires and indicators
VA questionnaires ask specific questions about signs,
symptoms, complaints, or contextual factors that will lead
to determining the most probable CoD. Such information
that indicates the possibility of specific causes is inclu-
sively termed as ‘indicators’. The review aimed to collate
evidence from field experience on: (i) specific modifica-
tions made to VA questionnaires and their rationales; (ii)
utility of specific indicators for CoD ascertainment; and
(iii) identification of most and least specific indicators
for reaching diagnoses. From the 125 studies reviewed,
contact was attempted with 45 randomly selected authors
(one per study, unless referred to another), and established
with 27. Limited feedback was gathered on specific indi-
cators, as most researchers were not able to report on
specific modifications made to the VA instruments, and
they found it challenging to give feedback on the utility,
Table 7. CoD removed from CoD list of the 2007 WHO VA
standard and subsumed into other categories in 2012 WHO
standard (n27)
2007 WHO VA standard cause
Subsumed into 2012
WHO VA cause
Other digestive disease VAs-98
Typhoid and paratyphoid VAs-01.99
Viral hepatitis VAs-01.99
Leishmaniasis VAs-01.99
Malignant melanoma of skin VAs-02.99
Malignant neoplasm of lymphoid,
haematopoietic and related tissue
VAs-02.99
Other specified neoplasms VAs-02.99
Other specified endocrine disorders VAs-98
Endocrine disorders, unspecified VAs-98
Other specified diseases of the respiratory
system
VAs-98
Respiratory disorder, unspecified VAs-98
Respiratory failure, not elsewhere
classified
VAs-98
Other diseases of intestine VAs-98
Disease of intestine, unspecified VAs-98
Specified mental disorders VAs-98
Mental disorders, unspecified VAs-98
Other specified disorders of the
nervous system
VAs-98
Nervous system disorders, not otherwise
classified
VAs-98
Alzheimer’s disease VAs-98
Other specified direct maternal causes VAs-09.99
Congenital viral diseases VAs-01.99
Congenital malformations of the nervous
system
VAs-10.06
Other specified disorders related to
perinatal period
VAs-10.99
Lack of food and/or water VAs-12.99
Legal intervention VAs-12.99
Accident, unspecified VAs-12.99
Other specified event, undetermined intent VAs-12.99
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Table 8. Simplified CoD list for 2012 WHO VA with corresponding ICD-10 codes
2012 verbal
autopsy code Verbal autopsy title
ICD-10 code
(to ICD) ICD-10 codes (from ICD)
VAs-01 Infectious and parasitic diseases
VAs-01.01 Sepsis A41 A40A41
VAs-01.02 Acute respiratory infection,
including pneumonia
J22; J18 J00J22
VAs-01.03 HIV/AIDS related death B24 B20B24
VAs-01.04 Diarrheal diseases A09 A00A09
VAs-01.05 Malaria B54 B50B54
VAs-01.06 Measles B05 B05
VAs-01.07 Meningitis and encephalitis G03; G04 A39; G00G05
VAs-01.08 Tetanus A35 (obstetric A34) A33A35
VAs-01.09 Pulmonary tuberculosis A16 A15A16
VAs-01.10 Pertussis A37 A37
VAs-01.11 Haemorrhagic fever A99 A90A99
VAs-01.99 Other and unspecified
infectious disease
B99 A20A38; A42A89; B00B19; B25B49; B55B99
Non-communicable diseases
VAs-98 Other and unspecified
non-communicable disease
R99 D55D89; E00E07; E15E35; E50E90; F00F99; G10G37;
G50G99; H00H95; J30J39; J47J99; K00K31; K40K93;
L00L99; M00M99; N00N16; N20N99; R00R69
VAs-02 Neoplasms
VAs-02.01 Oral neoplasms C06 C00C06
VAs-02.02 Digestive neoplasms C26 C15C26
VAs-02.03 Respiratory neoplasms C39 C30C39
VAs-02.04 Breast neoplasms C50 C50
VAs-02.05 Female reproductive neoplasms C57 C51C58
VAs-02.06 Male reproductive neoplasms C63 C60C63
VAs-02.99 Other and unspecified
neoplasms
C80 C07C14; C40C49; C60D48
VAs-03 Nutritional and endocrine disorders
VAs-03.01 Severe anaemia D64 D50D64
VAs-03.02 Severe malnutrition E46 E40E46
VAs-03.03 Diabetes mellitus E14 E10E14
VAs-04 Diseases of the circulatory system
VAs-04.01 Acute cardiac disease I24 (acute ischemic) I20I25
VAs-04.02 Stroke I64 I60I69
VAs-04.03 Sickle cell with crisis D57 D57
VAs-04.99 Other and unspecified cardiac
disease
I99 I10I15; I26I52; I70I99
VAs-05 Respiratory disorders
VAs-05.01 Chronic obstructive
pulmonary disease (COPD)
J44 J40J44
VAs-05.02 Asthma J45 (J46) J45J46
VAs-06 Gastrointestinal disorders
VAs-06.01 Acute abdomen R10 R10
VAs-06.02 Liver cirrhosis K74 K70K76
VAs-07 Renal disorders
VAs-07.01 Renal failure N19 N17N19
VAs-08 Mental and nervous system disorders
VAs-08.01 Epilepsy G40 G40G41
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value and specificity of individual questionnaire indica-
tors. The following alterations to standard instruments
were reported:
(1) Structural rearrangement of order and categoriza-
tion of questionnaire modules and changes in
targeted age groups;
Table 8 (Continued)
2012 verbal
autopsy code Verbal autopsy title
ICD-10 code
(to ICD) ICD-10 codes (from ICD)
VAs-09 Pregnancy-, childbirth and puerperium-related disorders
VAs-09.01 Ectopic pregnancy O00 O00
VAs-09.02 Abortion-related death O06 O03O08
VAs-09.03 Pregnancy-induced
hypertension
O13 (or O15 for
eclampsia)
O10O16
VAs-09.04 Obstetric haemorrhage O46 (antepartum)
O72 (postpartum)
O46; O67; O72
VAs-09.05 Obstructed labour O66 O63O66
VAs-09.06 Pregnancy-related sepsis O75.3 (antepartum)
O85 (postpartum)
O85; O75.3
VAs-09.07 Anaemia of pregnancy O99 O99.0
VAs-09.08 Ruptured uterus O71 O71
VAs-09.99 Other and unspecified maternal
cause
O05 O01O02; O20O45; O47O62; O68O70; O73O84;
O86O99
VAs-10 Neonatal causes of death
VAs-10.01 Prematurity P07 P05P07
VAs-10.02 Birth asphyxia P21 P20P22
VAs-10.03 Neonatal pneumonia P23 P23P25
VAs-10.04 Neonatal sepsis P63 P36
VAs-10.05 Neonatal tetanus A33 A33
VAs-10.06 Congenital malformation Q89 Q00Q99
VAs-10.99 Other and unspecified perinatal
cause of death
P96 P00P04; P08P15; P26P35; P37P94; P96
VAs-11 Stillbirths
VAs-11.01 Fresh stillbirth P95 P95
VAs-11.02 Macerated stillbirth P95 P95
VAs-12 External causes of death
VAs-12.01 Road traffic accident V89 V01V89
VAs-12.02 Other transport accident V99 V90V99
VAs-12.03 Accidental fall W19 W00W19
VAs-12.04 Accidental drowning and
submersion
W74 W65W74
VAs-12.05 Accidental exposure to smoke,
fire and flames
X09 X00X19
VAs-12.06 Contact with venomous animals
and plants
X29 X20X29
VAs-12.07 Accidental poisoning and
exposure to noxious substance
X49 X40X49
VAs-12.08 Intentional self-harm X84 X60X84
VAs-12.09 Assault Y09 X85Y09
VAs-12.10 Exposure to force of nature X39 X30X39
VAs-12.99 Other and unspecified external
cause of death
X59 S00T99; W20W64; W75W99; X50X59; Y10Y98
VA-99 Cause of death unknown R99 R99
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(2) Attempts to shorten the VA questionnaires by
removal and modification of questions related to
the duration of signs and symptoms; and
(3) Addition of disease-specific questions for local
conditions and research needs.
Overall, users considered the 2007 WHO VA standards
too long and time-consuming, expressing a desire for
shorter and more practical instruments. This process
of simplification was started by drafting diagnostic
criteria for each CoD by listing symptoms indicated in
the Oxford Text Book of Medicine (40). Subsequently,
experts identified essential indicators for differentiat-
ing CoD, and inclusion/exclusion was based on likely
recognition, recollection, and reporting in VA interviews.
Evidence of indicators’ utility was gathered by correlating
indicators from WHO VA standards, InterVA, and
PHMRC VA procedures. Furthermore, the simplification
of the WHO VA standards indicators was informed by
a progressive item reduction process based on the Tariff
method (27). Participating experts from PHMRC had
applied the Tariff method to the PHMRC validation
dataset and tested the effect of dropping items or sets
of items on chance-corrected concordance and CSMF
accuracy. These findings comprised one element of the
discussion on the evidence base for some CoD. Indicators
removed had low specificity and possibly generated
answers with low reliability due to recall difficulties.
These were mainly sub-indicators on the duration,
frequency, and development of signs and symptoms.
Other modifications made included the addition of
indicators from InterVA and PHMRC VA instruments,
the removal of overlapping indicators capturing very
similar information, and the inclusion of social context
indicators, facilitating use of the instrument in non-
enumerated populations. Overall, 164 indicators were
retained from the 2007 WHO VA standard, 57 new
indicators introduced and 244/408 indicators from the
2007 WHO VA standard excluded. Review by expert
groups  for relevance to the list of causes, reliability,
and feasibility  and comparison with machine assess-
ment analysis led to a reduction of 45.8% in number
of CoD-related indicators in relation to the WHO VA
standards, resulting in a total of 221 indicators (of
which various subsets apply to particular population
sub-groups).
Application of the 2012 WHO VA instrument to
facilitate routine surveillance
The need for consensus on simplified technical standards
and guidelines for VA, together with their widespread
endorsement and adoption, has become urgent. The
systematic use of the 2012 WHO VA instrument will
strengthen countries’ CRVS systems. In the past decade,
methodological developments in automated methods
for VA assessment have created a shift away from
limited individual-level and clinical paradigms towards
population-based epidemiological and public health think-
ing. To facilitate application in routine surveillance
systems, the new simplified VA instrument was specifi-
cally developed for automated ascertainment of CoD.
At present, the InterVA-4 model, as previously described
(41), is the only available automated interpretation tool
fully aligned with the 2012 WHO VA instrument. A
simple, automatically interpreted VA process will lead
to increased coverage of operational and representa-
tive CRVS systems. Shorter and simpler interviews not
needing physicians for CoD interpretation will facilitate
collection of adequate data for CRVS systems. CCVA
brings efficiency and consistency by providing a standar-
dized interpretation of VA. The new 2012 WHO VA
instrument will be piloted, modified, and integrated into
national health information systems.
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